
News|Articles|December 16, 2025
A look into the volume of Quest lab data for breast cancer research
Author(s)Quest Diagnostics
Key Takeaways
This datasheet illustrates how Quest Diagnostics' extensive de-identified lab data can be leveraged to accelerate and optimize clinical trials for breast cancer research. Researchers can use this real-world data to identify high concentrations of eligible patients, select optimal trial sites, find suitable principal investigators, and drive targeted patient recruitment efforts.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Trending on Applied Clinical Trials Online
1
ACT Brief: De-Identified Data Expands Trial Design, Global Production Normalizes, and FDA Updates Quality Framework
2
What 2026 Will Demand From Clinical Operations: Rethinking Efficiency, Access, and AI
3
If You Build It ... Will They Come?
4
Where Real-World Evidence Fits Along the Clinical Research Spectrum
5